Clinical Characteristics and Molecular Analysis of PIT1, PROP1,LHX3, and HESX1 in Combined Pituitary Hormone Deficiency Patients with Abnormal Pituitary MR Imaging

2003 ◽  
Vol 60 (6) ◽  
pp. 277-283 ◽  
Author(s):  
Sung-Su Kim ◽  
Youngho Kim ◽  
Young-Lim Shin ◽  
Gu-Hwan Kim ◽  
Tae-Ue Kim ◽  
...  
2007 ◽  
Vol 28 (7) ◽  
pp. 1369-1370 ◽  
Author(s):  
L.L.F. do Amaral ◽  
R.M. Ferreira ◽  
N.P.F.D. Ferreira ◽  
R.A. Mendonca ◽  
V.H.R. Marussi ◽  
...  

2009 ◽  
Vol 70 (1) ◽  
pp. 96-103 ◽  
Author(s):  
D. Kelberman ◽  
J. P. G. Turton ◽  
K. S. Woods ◽  
A. Mehta ◽  
M. Al-Khawari ◽  
...  

Author(s):  
Damian Rogoziński ◽  
Aleksandra Gilis-Januszewska ◽  
Łukasz Kluczyński ◽  
Magdalena Godlewska ◽  
Alicja Hubalewska-Dydejczyk

2016 ◽  
Vol 174 (6) ◽  
pp. R239-R247 ◽  
Author(s):  
Frederic Castinetti ◽  
Rachel Reynaud ◽  
Alexandru Saveanu ◽  
Nicolas Jullien ◽  
Marie Helene Quentien ◽  
...  

Over the last 5 years, new actors involved in the pathogenesis of combined pituitary hormone deficiency in humans have been reported: they included a member of the immunoglobulin superfamily glycoprotein and ciliary G protein-coupled receptors, as well as new transcription factors and signalling molecules. New modes of inheritance for alterations of genes encoding transcription factors have also been described. Finally, actors known to be involved in a very specific phenotype (hypogonadotroph hypogonadism for instance) have been identified in a wider range of phenotypes. These data thus suggest that new mechanisms could explain the low rate of aetiological identification in this heterogeneous group of diseases. Taking into account the fact that several reviews have been published in recent years on classical aetiologies of CPHD such as mutations ofPOU1F1orPROP1, we focused the present overview on the data published in the last 5 years, to provide the reader with an updated review on this rapidly evolving field of knowledge.


Sign in / Sign up

Export Citation Format

Share Document